The number of antibodies available for each target is variable with, for example, eight antibodies for the newly identified ALS disease gene NEK1 and over 700 for SOD1, an abundant and well-studied ALS gene. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.